Germline Mutation of <i>Bap1</i> Accelerates Development of Asbestos-Induced Malignant Mesothelioma
-
- Jinfei Xu
- 1Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
-
- Yuwaraj Kadariya
- 1Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
-
- Mitchell Cheung
- 1Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
-
- Jianming Pei
- 1Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
-
- Jacqueline Talarchek
- 1Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
-
- Eleonora Sementino
- 1Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
-
- Yinfei Tan
- 1Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
-
- Craig W. Menges
- 1Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
-
- Kathy Q. Cai
- 2Department of Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
-
- Samuel Litwin
- 3Biostatistics and Bioinformatics Facility, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
-
- Hongzhuang Peng
- 4Gene Expression and Regulation, Wistar Institute, Philadelphia, Pennsylvania.
-
- Jayashree Karar
- 4Gene Expression and Regulation, Wistar Institute, Philadelphia, Pennsylvania.
-
- Frank J. Rauscher
- 4Gene Expression and Regulation, Wistar Institute, Philadelphia, Pennsylvania.
-
- Joseph R. Testa
- 1Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
書誌事項
- 公開日
- 2014-08-13
- DOI
-
- 10.1158/0008-5472.can-14-1328
- 公開者
- American Association for Cancer Research (AACR)
この論文をさがす
説明
<jats:title>Abstract</jats:title> <jats:p>Malignant mesotheliomas are highly aggressive tumors usually caused by exposure to asbestos. Germline-inactivating mutations of BAP1 predispose to mesothelioma and certain other cancers. However, why mesothelioma is the predominate malignancy in some BAP1 families and not others, and whether exposure to asbestos is required for development of mesothelioma in BAP1 mutation carriers are not known. To address these questions experimentally, we generated a Bap1+/− knockout mouse model to assess its susceptibility to mesothelioma upon chronic exposure to asbestos. Bap1+/− mice exhibited a significantly higher incidence of asbestos-induced mesothelioma than wild-type (WT) littermates (73% vs. 32%, respectively). Furthermore, mesotheliomas arose at an accelerated rate in Bap1+/− mice than in WT animals (median survival, 43 weeks vs. 55 weeks after initial exposure, respectively) and showed increased invasiveness and proliferation. No spontaneous mesotheliomas were seen in unexposed Bap1+/− mice followed for up to 87 weeks of age. Mesothelioma cells from Bap1+/− mice showed biallelic inactivation of Bap1, consistent with its proposed role as a recessive cancer susceptibility gene. Unlike in WT mice, mesotheliomas from Bap1+/− mice did not require homozygous loss of Cdkn2a. However, normal mesothelial cells and mesothelioma cells from Bap1+/− mice showed downregulation of Rb through a p16(Ink4a)-independent mechanism, suggesting that predisposition of Bap1+/− mice to mesothelioma may be facilitated, in part, by cooperation between Bap1 and Rb. Drawing parallels to human disease, these unbiased genetic findings indicate that BAP1 mutation carriers are predisposed to the tumorigenic effects of asbestos and suggest that high penetrance of mesothelioma requires such environmental exposure. Cancer Res; 74(16); 4388–97. ©2014 AACR.</jats:p>
収録刊行物
-
- Cancer Research
-
Cancer Research 74 (16), 4388-4397, 2014-08-13
American Association for Cancer Research (AACR)